falsefalse
Rapid Readouts: JAVELIN Bladder 100 Phase III Interim Analysis - Episode 1

The JAVELIN Bladder 100 Phase III Trial Results

June 16, 2020

Now Playing: The JAVELIN Bladder 100 Phase III Trial Results

Now Playing
EP. 1: The JAVELIN Bladder 100 Phase III Trial Results
EP. 1: The JAVELIN Bladder 100 Phase III Trial Results

Related Content:

Rapid ReadoutsASCO
Isatuximab (Isa) subcutaneous (SC) via an on-body delivery system (OBDS) vs Isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): Results of the randomized, non-inferiority, Phase 3 IRAKLIA study
Sacituzumab Govitecan Plus Pembrolizumab vs Chemotherapy Plus Pembrolizumab in Patients With Previously Untreated, PD-L1 Positive, Advanced or Metastatic Triple-Negative Breast Cancer: Primary Results From the Randomized, Phase 3 ASCENT-04/KEYNOTE-D19 Study
Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL): A Matching-Adjusted Indirect Comparison (MAIC)
x